A visionary in drug development, Jeff Geschwind, MD founded Cage Pharma. His research focuses on novel cancer drugs that disrupt tumor metabolism, specifically targeting glycolysis. This approach aims to starve cancer cells of their essential energy source. https://www.usaveinclinics.com/vein-specialist/jean-francois-geschwind/